Plant ID: NPO16333
Plant Latin Name: Chenopodium album
Taxonomy Genus: Chenopodium
Taxonomy Family: Chenopodiaceae
NCBI TaxonomyDB:
3559
Plant-of-the-World-Online:
55993-2
Anthelmintic; Antiphlogistic; Antirheumatic; Contraceptive; Laxative; Odontalgic
Brazil; Canada; Madagascar; Italy; Bangladesh; Kenya; Lebanon; Nepal; France; Bahamas; Ethiopia; Norway; Netherlands; Ireland; Austria; Swaziland; Bolivia; Cameroon; Ecuador; Turkmenistan; Uzbekistan; Belarus; Algeria; Cuba; Iceland; Zambia; Cape Verde; United States; Zimbabwe; China; Chile; Belgium; Germany; Dominican Republic; Kazakhstan; Spain; Ukraine; Mauritania; Georgia; Libya; Denmark; Poland; Finland; New Caledonia; Turkey; Mauritius; Morocco; Sweden; Seychelles; Namibia; Japan; Switzerland; New Zealand; Russia; Bulgaria; Pakistan; Romania; Albania; Angola; Portugal; Mexico; Egypt; Tajikistan; South Africa; India; Peru; United Kingdom; Lesotho; Djibouti; Mozambique; Tunisia; Colombia; Greece; Sri Lanka; Hungary; Taiwan; Cyprus; Botswana
ADRA2C; ADRA2A; | |
NMUR2; | |
GAA; ACHE; | |
MAPK1; | |
POLB; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Peptide receptor (family A GPCR) | NMUR2 | Neuromedin-U receptor 2 | Q9GZQ4 | CHEMBL1075144 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Small molecule receptor (family A GPCR) | ADRA2C | Alpha-2c adrenergic receptor | P18825 | CHEMBL1916 |
Small molecule receptor (family A GPCR) | ADRA2A | Alpha-2a adrenergic receptor | P08913 | CHEMBL1867 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0065007; biological regulation | GO:0035625; epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 6.752E-07 | 4.575E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0032811; negative regulation of epinephrine secretion | 6.752E-07 | 4.575E-03 | ADRA2A, ADRA2C |
BP | GO:0032501; multicellular organismal process | GO:0006940; regulation of smooth muscle contraction | 1.261E-06 | 4.575E-03 | ADRA2A, ADRA2C, NMUR2 |
MF | GO:0060089; molecular transducer activity | GO:0004938; alpha2-adrenergic receptor activity | 3.377E-07 | 4.575E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0010700; negative regulation of norepinephrine secretion | 3.149E-06 | 7.618E-03 | ADRA2A, ADRA2C |
MF | GO:0005488; binding | GO:0051379; epinephrine binding | 3.149E-06 | 7.618E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0030168; platelet activation | 6.186E-06 | 1.225E-02 | ADRA2A, ADRA2C, MAPK1 |
MF | GO:0003824; catalytic activity | GO:0004574; oligo-1,6-glucosidase activity | 7.247E-04 | 1.962E-01 | GAA |
CC | GO:0016020; membrane | GO:0005886; plasma membrane | 7.872E-04 | 2.065E-01 | ACHE, ADRA2A, ADRA2C, GAA, MAPK1, NMUR2 |
CC | GO:0044464; cell part | GO:0030424; axon | 3.543E-03 | 4.691E-01 | ADRA2C, MAPK1 |
CC | Unclassified; | GO:0031143; pseudopodium | 6.145E-03 | 6.055E-01 | MAPK1 |
CC | GO:0044464; cell part | GO:0032839; dendrite cytoplasm | 9.026E-03 | 7.473E-01 | MAPK1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09130 Environmental Information Processing | 09132 Signal transduction | hsa04022 | cGMP-PKG signaling pathway | 1.953E-05 | 1.836E-03 | MAPK1, ADRA2C, ADRA2A |
09130 Environmental Information Processing | 09133 Signaling molecules and interaction | hsa04080 | Neuroactive ligand-receptor interaction | 8.828E-05 | 4.149E-03 | NMUR2, ADRA2C, ADRA2A |
09150 Organismal Systems | 09156 Nervous system | hsa04725 | Cholinergic synapse | 6.295E-04 | 1.972E-02 | ACHE, MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05203 | Viral carcinogenesis | 2.122E-03 | 4.988E-02 | POLB, MAPK1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04370 | VEGF signaling pathway | 2.116E-02 | 6.113E-02 | MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 2.150E-02 | 6.113E-02 | MAPK1 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 1.978E-02 | 6.113E-02 | MAPK1 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 2.288E-02 | 6.113E-02 | MAPK1 |
09150 Organismal Systems | 09151 Immune system | hsa04664 | Fc epsilon RI signaling pathway | 2.356E-02 | 6.113E-02 | MAPK1 |
09150 Organismal Systems | 09156 Nervous system | hsa04720 | Long-term potentiation | 2.288E-02 | 6.113E-02 | MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis | G70.0 | ACHE; |
C00-D49: Neoplasms | Cancer | C00-C96 | ACHE; |
K00-K95: Diseases of the digestive system | Xerostomia | K11.7, R68.2 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | ACHE; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | ACHE; |
NA: NA | Upper abdominal bloating | NA | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis diagnosis | G70.0 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | ACHE; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Epileptic seizures | G40, P90, R56 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mild cognitive impairment | F06.7 | ACHE; |
NA: NA | Early satiation associated with functional dyspepsia | NA | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poison intoxication | T36-T50 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poisoning due to pesticides and chemicals | T36-T50 | ACHE; |
N00-N99: Diseases of the genitourinary system | Urinary dysfunction | N39.3-N39.4 | ACHE; |